Treatment of Antimicrobial Resistant STIs: Mycoplasma Genitalium, Gonorrhoea and Others

Back to events

Both Mycoplasma Genitalium (MG) and Gonorrhoea are relatively common in Australia. Both STIs have developed anti-microbial resistance in recent years, rendering them increasingly difficult to treat. This course will delve into treating evolving drug resistant STIs, including Gonorrhoea and MG.

Antimicrobial resistance refers to the ability of an infection to resist the effects of medicines used to treat the infection. It is sometimes also referred to as ‘drug resistance’. Drug resistance can be caused by the suboptimal or overuse use of antibiotics, non-compliance with treatment regimens and/or poor quality treatment.

Hosted by the Victorian HIV and Hepatitis Integrated Training and Learning program, this session will cover effective methods of testing and treatment in the presence of antimicrobial resistance. 

Format: Online, 2 hour session.

Learning Methods: Presentation, Case Discussion, Q&A.

Presenter & Facilitator: Dr Melanie Bissessor, Sexual Health Physician - Melbourne Sexual Health Centre

Continuing Professional Development: This activity has been approved for the following hours and type: 2 Educational activities hours for the RACGP Triennium 23-25. 

Learning outcomes:

  • Define the epidemiology and mechanisms of microbial resistance in STIs
  • Accurately identify the testing methods for the presence of microbial resistance
  • Discuss treatment options for microbial resistant STIs with patients
  • Describe other emerging STI resistance possibilities and options for specialist advice and referral in managing treatment 


Online, Victoria